Search results
Showing 3631 to 3645 of 8238 results
Past technology appraisal appeals and decisions
A timeline showing where in the NICE evaluation process companies will be charged.
A step-by-step summary about how we develop our technology appraisal guidance.
Technology appraisal and highly specialised technologies appeals
Learn about the NICE Technology Appraisal and Highly Specialised Technologies appeals process, including how decisions are made, the criteria for appeals, and the role of the appeal panel in ensuring fair and transparent evaluations of health technologies.
Fees for technology appraisals and highly specialised technologies
NICE fees for technology appraisals and highly specialised technologies
NICE's technology appraisal guidance makes recommendations on the use of new and existing medicines and other treatments within the NHS.
Clarification on demonstrating patient access to medicines and treatments recommended by NICE Technology Appraisal (TA) or Highly Specialised Technologies (HST) guidance.
NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.
Home What NICE does Our guidance About technology appraisal guidance {"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":
Data on the cancer recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Data on the recommendations made by our technology appraisal programme. Includes information on the number of positive recommendations we've made.
Home What NICE does Our guidance About technology appraisal guidance Our methods and processes (health technology evaluation manual)...
Technology appraisal submission templates and supporting documents
All the templates and supporting documents you need to make a technology appraisals submission with NICE.
Engage at the optimal time for your technology appraisal, to achieve NICE guidance at the same time as marketing authorisation.
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritis (HTG521)
Evidence-based recommendations on enzyme-linked immunosorbent assay (ELISA) tests for therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors in rheumatoid arthritis. The tests are Promonitor, IDKmonitor, LISA-tracker, RIDASCREEN, MabTrack, and those used by Sanquin Diagnostic Services.